Exchange Offer — AstraZeneca PLC (US0463531089)

https://www.bcc-invest.kz/storage/app/uploads/public/691/468/c26/691468c262cfc173393361.png

11.11.2025

AstraZeneca PLC has announced the termination of its Depositary Receipt (DR) Program.
The termination will take effect on February 2, 2026.

Investors have two options:
1️⃣ Take no action — Depositary Receipts will be cancelled by the agent, and the underlying ordinary shares will be sold. Cash proceeds from the sale will be distributed to DR holders. This is the default option.
2️⃣ Surrender DRs for local shares — Investors may submit instructions to exchange DRs for ordinary shares under event No. 1465892. The cancellation may be subject to related fees.

The payment date and amount for the cash option will be announced later upon receipt of information from the depositary and depend on market liquidity.
All settlement transactions for this ISIN will be closed as of the effective date.